Community lists
Curadoria · Saúde

Biotech

Por InspectStocksPublished 14 de out. de 202619 companies0 follower

Drug developers with approved medicines, built mainly on biologic and genetic science.

Agrupadas com a ajuda de um modelo de IA e revisadas pelos nossos editores. A linha abaixo de cada empresa diz por que ela está aqui.

Sign in to followSign in to copy
Download image
CartõesNíveis
A
  • GILDGilead Sciences
    US$ 169,73+40,9% 1Y

    Sells medicines for HIV, liver disease and cancer

  • BIIBBiogen
    US$ 253,39+56,9% 1Y

    Develops and sells therapies for neurological diseases

  • NBIXNeurocrine Biosciences
    US$ 174,35+18,7% 1Y

    Develops and sells therapies for neurological and endocrine disorders

  • EXELExelixis
    US$ 70,71+62,2% 1Y

    Develops and sells cancer therapies

  • JAZZJazz Pharmaceuticals
    US$ 248,18+81,5% 1Y

    Develops and sells neuroscience and oncology therapies

  • HALOHalozyme Therapeutics
    US$ 101,69+44,0% 1Y

    Licenses drug delivery technology and sells enzyme-based therapies

  • KRYSKrystal Biotech
    US$ 308,82+52,1% 1Y

    Develops and sells topical gene therapies for rare diseases

  • CORTCorcept Therapeutics
    US$ 74,52-4,9% 1Y

    Develops and sells cortisol-modulating therapies

B
  • VRTXVertex Pharmaceuticals
    US$ 547,02+26,0% 1Y

    Develops and sells cystic fibrosis and other medicines

  • ALNYUm degrau abaixo porque o crescimento está perdendo forçaAlnylam Pharmaceuticals
    US$ 159,80-64,7% 1Y

    Develops and sells RNAi therapeutics

  • BBIOBridgeBio Pharma
    US$ 79,53+20,1% 1Y

    Develops therapies for genetic diseases

  • BMRNBioMarin Pharmaceutical
    US$ 58,32+5,4% 1Y

    Develops and sells therapies for rare genetic diseases

C
  • REGNRegeneron Pharmaceuticals
    US$ 959,45+41,5% 1Y

    Develops and sells antibody therapies for eye, allergy and cancer conditions

  • MRNAModerna
    US$ 248,70+831,1% 1Y

    Develops mRNA vaccines and therapies

  • INSMInsmed
    US$ 120,64-37,9% 1Y

    Develops and sells therapies for rare lung diseases

  • UTHRUm degrau abaixo porque o crescimento está perdendo forçaUnited Therapeutics
    US$ 595,58+29,0% 1Y

    Sells therapies for pulmonary arterial hypertension

  • INCYIncyte
    US$ 122,23+12,9% 1Y

    Develops and sells oncology and inflammation therapies

D
  • ASNDAscendis Pharma A/S
    US$ 259,10+30,1% 1Y

    Develops and sells endocrinology rare disease therapies

F
  • BNTXBioNTech
    US$ 87,64-21,5% 1Y

    Develops mRNA vaccines and cancer therapies

DiscussionNo comments yet

Sign in to join the discussion

Be civil and stick to the companies. Comments are opinions, not advice.

    Lists are their owners' own, and notes and comments are opinions. Grades describe businesses from their filings; nothing here is a recommendation to buy or sell.